Published in Cancer Weekly, January 14th, 2003
The grant, entitled "Cytokine Conjugates for Treating Thrombocytopenia", supports research to develop long acting, second generation forms of interleukin-11 (IL-11) for the treatment of chemotherapy-induced thrombocytopenia. Receipt of the entire grant award is contingent upon the achievement of certain research milestones.
George (Joe) Cox, PhD, company president and principal investigator for the grant, stated, "This continuing grant award...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.